Oxford Asset Management’s Guardant Health GH Stock Holding History

Oxford Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$205K	Sell	1,364 -1,356	-50%	-$147K	0.1%	309
2026 Q1	$251K	Buy	+2,720	New	+$273K	0.1%	306
2025 Q4	–	Sell	-12,358	Closed	-$772K	–	594
2025 Q3	$772K	Buy	+12,358	New	+$672K	0.25%	113
2024 Q3	–	Sell	-8,648	Closed	-$250K	–	364
2024 Q2	$250K	Sell	8,648 -7,352	-46%	-$171K	0.24%	169
2024 Q1	$330K	Buy	+16,000	New	+$343K	0.34%	97
2019 Q1	–	Sell	-52,473	Closed	-$1.97M	–	1773
2018 Q4	$1.97M	Buy	+52,473	New	+$1.93M	0.05%	473

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Oxford Asset Management's GH Position: Q2 2026 in Review

Oxford Asset Management reduced its Guardant Health (GH) stake by 50% in Q2 2026, selling an estimated $147K and leaving 1,364 shares worth $205K. The position accounts for 0.1% of the portfolio, ranked #309.

Oxford Asset Management first reported a position in GH in Q4 2018 and has held it in 6 quarters since. The position peaked at $1.97M in Q4 2018. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Oxford Asset Management held 1,364 shares of Guardant Health worth $205K as of Q2 2026.
Oxford Asset Management sold 1,356 Guardant Health shares in Q2 2026, an estimated $147K.
Guardant Health made up 0.1% of Oxford Asset Management's portfolio in Q2 2026, its #309 holding.
Oxford Asset Management first reported a position in Guardant Health in Q4 2018 and has held it in 6 quarters since.
Oxford Asset Management's Guardant Health position peaked at $1.97M in Q4 2018.
600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.